IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGG)— 510(k) K032850

Substantially Equivalent

Immco Diagnostics, Inc.

FDA 510(k) clearance K032850 for IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGG), Substantially Equivalent on 2004-03-18. Applicant: Immco Diagnostics, Inc..

Clearance details

Applicant: Immco Diagnostics, Inc.
Product code: Code NBT
Advisory panel: Immunology
Date received: 2003-09-12
Decision date: 2004-03-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Buffalo, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.